Characteristics of the 6th Japanese wave of COVID-19 in hemodialysis patients

Munenori Haruta1, Shigeru Otsubo1,2, Yuriko Otsubo2

  • 1Department of Clinical Engineering, Faculty of Human Care at Makuhari, Tohto University, 1-1 Hibino, Mihama-Ward, Chiba-City, Chiba-Prefecture 261-0021 Japan.

Renal Replacement Therapy
|December 7, 2022
PubMed

Insights

COVID-19 outcomes improved for hemodialysis patients in Japan during the 6th wave. Increased vaccination rates and advanced treatments, including neutralizing antibodies and molnupiravir, led to better prognoses and fewer critical cases.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19 poses significant risks to hemodialysis patients.
  • The 6th wave in Japan was primarily driven by the Omicron variant.
  • Understanding clinical characteristics during different infection waves is crucial for patient management.

Purpose of the Study:

  • To compare the clinical characteristics and outcomes of hemodialysis patients with COVID-19 between the 1st-5th waves and the 6th wave in Japan.
  • To assess the impact of vaccination and new treatments on patient prognosis.

Main Methods:

  • Retrospective cohort study comparing two groups of hemodialysis patients.
  • Group 1: Patients admitted from January 2022 onwards (6th wave, n=53).
  • Group 2: Patients admitted during the 1st-5th waves (n=47).

Main Results:

  • The 6th wave group had significantly higher vaccination rates (96.2% vs 10.6%).
  • Use of neutralizing antibodies and molnupiravir was more frequent in the 6th wave group.
  • Critical COVID-19 disease was absent in the 6th wave group, compared to 21.3% in the earlier waves.

Conclusions:

  • Hemodialysis patients in Japan experienced improved outcomes during the 6th COVID-19 wave.
  • Increased vaccination coverage and advancements in antiviral treatments likely contributed to the better prognosis.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
186
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
92
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
109
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
60
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
767
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
58